ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,728Medicare Part D Prescriptions Filled, Including Refills

Rank: 191 out of 939

$499K Total Retail Price of All Prescriptions

Rank: 244 out of 939

421 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 421 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

22% of this provider’s 421 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 10,921 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
SIMVASTATIN 717 656 1 2
POTASSIUM CHLORIDE 595 571 2 9
HYDROCODONE-ACETAMINOPHEN 451 383 S3 3 1
FUROSEMIDE 339 321 4 7
OMEPRAZOLE 305 271 5 5
METOPROLOL TARTRATE 292 253 6 10
WARFARIN SODIUM 247 247 7 17
LEVOTHYROXINE SODIUM 242 222 8 4
MELOXICAM 199 175 9 14
LOSARTAN-HYDROCHLOROTHIAZIDE 197 180 10 55
TRAMADOL HCL 192 168 11 16
AMLODIPINE BESYLATE 192 185 11 6
LISINOPRIL 190 176 13 3
DIGOXIN 178 174 14 45
METFORMIN HCL 174 174 15 8
TRIAMTERENE-HCTZ 170 170 16 33
METOPROLOL SUCCINATE 156 147 17 21
AZITHROMYCIN 154 129 18 32
ATENOLOL 144 144 19 19
LOSARTAN POTASSIUM 143 140 20 29
CRESTOR 140 132 21 34
ATORVASTATIN CALCIUM 136 129 22 22
CLOPIDOGREL 128 124 23 28
NEXIUM 121 121 24 18
HYDROCHLOROTHIAZIDE 111 106 25 12
CEFPROZIL 111 99 25 213
PLAVIX 109 106 27 48
TRAZODONE HCL 106 106 28 26
DIOVAN 101 97 29 50
RAMIPRIL 99 81 30 91
SERTRALINE HCL 98 92 31 24
CARVEDILOL 96 89 32 25
CITALOPRAM HBR 94 94 33 15
ALLOPURINOL 88 88 34 31
QUETIAPINE FUMARATE 86 80 35 69
CIPROFLOXACIN HCL 86 79 35 54
ISOSORBIDE MONONITRATE ER 80 79 37 53
GLIMEPIRIDE 78 78 38 37
LEVOFLOXACIN 78 70 38 86
TAMSULOSIN HCL 75 75 40 27
CEPHALEXIN 71 61 41 77
NAMENDA 71 71 41 49
BISOPROLOL-HYDROCHLOROTHIAZIDE 71 59 41 129
CYCLOBENZAPRINE HCL 71 55 R 41 36
ENALAPRIL MALEATE 62 62 45 65
SEROQUEL 61 60 46 139
FLUTICASONE PROPIONATE 61 57 46 43
POLYETHYLENE GLYCOL 3350 61 61 46 57
LOVASTATIN 60 60 49 46
BUSPIRONE HCL 60 60 49 123
AMITRIPTYLINE HCL 58 57 R 51 38
VERAPAMIL ER 53 53 52 85
GABAPENTIN 52 43 53 11
ATENOLOL-CHLORTHALIDONE 51 51 54 164
DONEPEZIL HCL 51 51 54 30
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 21, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.